ENTRY       D12406                      Drug
NAME        Ensovibep (INN);
            Ensovibep (genetical recombination) (JAN)
FORMULA     C3730H6063N1067O1166
EXACT_MASS  84461.7936
MOL_WEIGHT  84511.5005
SEQUENCE    GSDLGKKLLE AARAGQDDEV RELLKAGADV NAKDYFSHTP LHLAARNGHL KIVEVLLKAG
            ADVNAKDFAG KTPLHLAANE GHLEIVEVLL KAGADVNAQD IFGKTPADIA ADAGHEDIAE
            VLQKAAGSPT PTPTTPTPTP TTPTPTPTGS DLGKKLLEAA RAGQDDEVRE LLKAGADVNA
            KDYFSHTPLH LAARNGHLKI VEVLLKAGAD VNAKDFAGKT PLHLAANEGH LEIVEVLLKA
            GADVNAQDIF GKTPADIAAD AGHEDIAEVL QKAAGSPTPT PTTPTPTPTT PTPTPTGSDL
            GKKLLQAARA GQLDEVRELL KAGADVNAKD REGITPLHLA AQHGHLEIVE VLLKAGADVN
            AKDVWGRTPL HLAAWQGHLE IVEVLLKAGA DVNAKDLAGA TPLHVAALYG HLEIVEVLLK
            AGADVNAQDK SGKTPADLAA RAGHQDIAEV LQKAAGSPTP TPTTPTPTPT TPTPTPTGSD
            LGKKLLQAAR AGQLDEVREL LKAGADVNAK DREGKTPLHV AAQEGHLEIV EVLLKAGADV
            NAKDVWGRTP LHLAAWIGHL EIVEVLLKAG ADVNAKDVSG ATPLHAAALH GHLEIVEVLL
            NAGADVNAQD KSGKTPADLA ARAGHQDIAE VLQKAAGSPT PTPTTPTPTP TTPTPTPTGS
            DLGKKLLQAA RAGQLDEVRE LLKAGADVNA KDQEGITPLH VAAHQGHLEI VEVLLKAGAD
            VNAKDVWGRT PLHLAAWRGH LEIVEVLLKA GADVNAKDHA GATPLHAAAL SGHLEIVEVL
            LKAGADVNAQ DKSGKTPADL AARAGHQDIA EVLQAA
  TYPE      Peptide
CLASS       Antiviral
             DG03174  Anti-SARS-CoV-2 agent
EFFICACY    Antiviral
COMMENT     ankyrin repeat
TARGET      SARS-CoV-2 spike glycoprotein [KO:K24152]
  PATHWAY   ko03230(K24152)  Viral genome structure
            ko05171(K24152)  Coronavirus disease - COVID-19
BRITE       Drug groups [BR:br08330]
             Antiviral
              DG03174  Anti-SARS-CoV-2 agent
               D12406  Ensovibep
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Coronavirus spike protein
                D12406  Ensovibep (INN)
DBLINKS     CAS: 2451126-06-8
///
